Stryker Corporation Expects Hip Recall to Cost Millions
The Stryker Corporation has estimated that the hip implant recall of its Rejuvenate and ABG II modular-neck hip devices in June of 2012 will cost the corporation between $190 million to $390 million.
Stryker has advised all patients who have the Rejuvenate Modular or ABG II modular-neck hip implants to consult a doctor, even if they are not experiencing symptoms of pain or swelling at or around their hips. This is because these devices have been known to cause high levels of metals to be found in patients’ bloodstreams. It is still unclear what the long-term consequences may be of this metal exposure.
The medical community has been clear that it is important for patients with these devices to be seen by their physicians. An orthopedic surgeon at the Mayo clinic who was interviewed for the article attached to this blog has stated that her issue of greatest concern is the tissue damage that can be caused by these devices. Damage to the muscles, tendons and soft tissue can generally not be repaired, according to this doctor. Damage to bone is more easily repaired.
Blood tests and imaging studies are required to determine the level of damage caused by these devices as well as a treatment plan going forward.
GreeningLaw, P.C. is actively investigating and handling these cases and stands ready to help patients with these unfortunate devices implanted in them.